Q3 2024 SANUWAVE Health Inc Earnings Call Transcript
Key Points
- SANUWAVE Health Inc (SNWVD) reported its highest quarterly revenues in company history, with Q3 2024 revenue reaching $9.4 million, an 89% increase year-over-year.
- The company achieved a significant rise in gross margins to 75.5%, attributed to a successful transition to a new contract manufacturer and positive pricing impacts.
- SANUWAVE Health Inc (SNWVD) turned cash generative in Q3 2024, marking a positive shift in financial health.
- The company successfully completed a reverse stock split and warrant exchange, simplifying and stabilizing its capital structure.
- The sales of 124 systems in Q3 2024 marked a substantial increase from previous quarters, indicating strong market demand and successful customer engagement.
- The company reported a net loss of $20.7 million for Q3 2024, although this was an improvement from the previous year's loss.
- Forecasting revenue remains challenging due to the 'pigs and pythons' problem, with system sales being less predictable, especially with larger customers.
- Operating expenses increased by $1 million year-over-year, primarily due to higher selling expenses.
- International revenue growth appears sluggish compared to the strong performance in the U.S. market.
- The company identified material weaknesses in its internal control over financial reporting, which it is actively working to address.
Please stand by. Your program is about to begin. If you need assistance during your conference today, please press star zero.
Good day, everyone and welcome to today's SANUWAVE Health Inc announces highest quarterly revenues in company history. Q3 2024 results. At this time, all participants are in a listen-only mode later. You will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing the start and one on your telephone keypad, you may withdraw yourself from the queue by pressing star to please note this call is being recorded and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Morgan Frank, Chairman and CEO of SANUWAVE Health Inc.
Thank you very much. So welcome everyone to SANUWAVE Health Inc third quarter, 2024 earnings call. As many of you saw our form 10-Q was filed with the SEC last night. Our arrange release was issued this morning and our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
